Cargando…
Tofacitinib for the treatment of inflammatory bowel disease-associated arthritis: two case reports
BACKGROUND: Musculoskeletal manifestations are common extraintestinal manifestations of inflammatory bowel disease. Tofacitinib is a Janus kinase inhibitor approved for treating rheumatoid arthritis and ulcerative colitis. There are limited data on the efficacy of tofacitinib in managing inflammator...
Autores principales: | Momen Majumder, Muhammad Shoaib, Haq, Syed Atiqul, Rasker, Johannes J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9976468/ https://www.ncbi.nlm.nih.gov/pubmed/36855206 http://dx.doi.org/10.1186/s13256-023-03796-2 |
Ejemplares similares
-
Translation, cross‐cultural adaptation and validation of the Pain Catastrophizing Scale (PCS) into Bengali in patients with chronic non‐malignant musculoskeletal pain
por: Majumder, Muhammad Shoaib Momen, et al.
Publicado: (2020) -
Digital Gangrene: An Unusual Manifestation of Non-Hodgkin Lymphoma
por: Momen Majumder, Muhammad Shoaib, et al.
Publicado: (2022) -
Effects of tofacitinib on the clinical features of periodontitis in patients with rheumatoid arthritis: two case reports
por: Kobayashi, Tetsuo, et al.
Publicado: (2019) -
Use of Tofacitinib for the Treatment of Arthritis Associated With Ulcerative Colitis
por: Wang, Wenfei, et al.
Publicado: (2019) -
Sequential Tocilizumab and Tofacitinib Treatment for Systemic Juvenile Idiopathic Arthritis: a Case Report
por: Zhang, Ye, et al.
Publicado: (2022)